Connecting Microbial Population Genetics with Microbial Pathogenesis Engineering Microfluidic Cell Arrays for High-throughput Interrogation of Host-Pathogen Interaction

A bacterial species typically includes heterogeneous collections of genetically diverse isolates. How genetic diversity within bacterial populations influences the clinical outcome of infection remains mostly indeterminate. In part, this is due to a lack of technologies that can enable contemporaneous systems-level interrogation of host-pathogen interaction using multiple, genetically diverse bacterial strains. This chapter presents a prototype microfluidic cell array (MCA) that allows simultaneous elucidation of molecular events during infection of human cells in a semi-automated fashion. It shows that infection of human cells with up to sixteen genetically diverse bacterial isolates can be studied simultaneously. The versatility of MCAs is enhanced by incorporation of a gradient generator that allows interrogation of host-pathogen interaction under four different concentrations of any given environmental variable at the same time. Availability of high throughput MCAs should foster studies that can determine how differences in bacterial gene pools and concentration-dependent environmental variables affect the outcome of host-pathogen interaction.

Dynamic Modeling and Parameter Identification for Biological Networks

Then, two different parameter identification techniques are presented for the proposed models. One is based on a least squares procedure, which treats the signals provided by a high gain observer; the other one is based on a Mixed Extended Kalman Filter. Prior to the estimation phase, identifiability and sensitivity analyses are used to determine which parameters can be and/or should be estimated. The procedures are tested and compared by means of data obtained by in silico experiments.

Cancer and Signaling Pathway Deregulation

Cancer is a complex disease that is associated with a variety of genetic aberrations. The diagnosis and treatment of cancer have been difficult because of poor understanding of cancer and lack of effective cancer therapies. Many studies have investigated cancer from different perspectives. It remains unclear what molecular mechanisms have triggered and sustained the transition of normal cells to malignant tumor cells in cancer patients. This chapter gives an introduction to the genetic aberrations associated with cancer and a brief view of the topics key to decode cancer, from identifying clinically relevant cancer subtypes to uncovering the pathways deregulated in particular subtypes of cancer.

Network-Driven Analysis Methods and their Application to Drug Discovery

Drug discovery and development face tremendous challenges to find promising intervention points for important diseases. Any therapeutic agent targeting such an intervention point must prove its efficacy and safety in patients. Success rates measured from first studies in human to registration average around 10% only. Over the last decade, massive knowledge on biological systems has been accumulated and genome-scale primary data are produced at an ever increasing rate. In parallel, methods to use that knowledge have matured. This chapter will present some of the problems facing the pharmaceutical industry and elaborate on the current state of network-driven analysis methods. It will focus especially on semi-quantitative methods that are applicable to large-scale data analysis and point out their potential use in many relevant drug discovery challenges.

Knowledge-Driven, Data-Assisted Integrative Pathway Analytics

Target and biomarker selection in drug discovery relies extensively on the use of various genomics platforms. These technologies generate large amounts of data that can be used to gain novel insights in biology. There is a strong need to mine these information-rich datasets in an effective and efficient manner. Pathway and network based approaches have become an increasingly important methodology to mine bioinformatics datasets derived from ‘omics’ technologies. These approaches also find use in exploring the unknown biology of a disease or functional process. This chapter provides an overview of pathway databases and network tools, network architecture, text mining and existing methods used in knowledge-driven data analysis. It shows examples of how these databases and tools can be used integratively to apply existing knowledge and network-based approach in data analytics.

Single Nucleotide Polymorphism and its Application in Mapping Loci Involved in Developing Human Diseases and Traits

Common diseases or traits in humans are often influenced by complex interactions among multiple genes as well as environmental and lifestyle factors rather than being attributable to a genetic variation within a single gene. Identification of genes that confer disease susceptibility can be facilitated by studying DNA markers such as single nucleotide polymorphism (SNP) associated with a disease trait. Genome-wide association approaches offers a systematic analysis of the association of hundreds of thousands of SNPs with a quantitative complex trait. This method has been successfully applied to a wide variety of common human diseases and traits, and has generated valuable findings that have improved the understanding of the genetic basis of many complex traits. This chapter outlines the general mapping process and methods, highlights the success stories, and describes some limitations and challenges that lie ahead.

A Multiscale Computational Model of Chemotactic Axon Guidance

In the development of the nervous system, the migration of neurons driven by chemotactic cues has been known since a long time to play a key role. In this mechanism, the axonal projections of neurons detect very small differences in extracellular ligand concentration across the tiny section of their distal part, the growth cone. The internal transduction of the signal performed by the growth cone leads to cytoskeleton rearrangement and biased cell motility. A mathematical model of neuron migration provides hints of the nature of this process, which is only partially known to biologists and is characterized by a complex coupling of microscopic and macroscopic phenomena. This chapter focuses on the tight connection between growth cone directional sensing as the result of the information collected by several transmembrane receptors, a microscopic phenomenon, and its motility, a macroscopic outcome. The biophysical hypothesis investigated is the role played by the biased re-localization of ligand-bound receptors on the membrane, actively convected by growing microtubules. The results of the numerical simulations quantify the positive feedback exerted by the receptor redistribution, assessing its importance in the neural guidance mechanism.

Visualization of Protein 3D Structures in ‘Double-Centroid’ Reduced Representation

This article is of two parts: (a) the development of a protein reduced representation and its implementation in a Web server; and (b) the use of the reduced protein representation in the modeling of the binding site of a given ligand and the screening for the model in other protein 3D structures. Current methods of reduced protein 3D structure representation such as the Ca trace method not only lack essential molecular detail, but also ignore the chemical properties of the component amino acid side chains. This chapter describes a reduced protein 3D structure representation called “double-centroid reduced representation” and presents a visualization tool called the “DCRR Web Server” that graphically displays a protein 3D structure in DCRR along with non-covalent intra- and intermolecular hydrogen bonding and van der Waals interactions. In the DCRR model, each amino acid residue is represented as two points: the centroid of the backbone atoms and that of the side chain atoms; in the visualization Web server, they and the non-bonded interactions are color-coded for easy identification. The visualization tool in this chapter is implemented in MATLAB and is the first for a reduced protein representation as well as one that simultaneously displays non-covalent interactions in the molecule. The DCRR model reduces the atomicity of the protein structure by ~75% while capturing the essential chemical properties of the component amino acids. The second half of this chapter describes the application of this reduced representation to the modeling and screening of ligand binding sites using a data model termed the “tetrahedral motif.” This type of ligand binding site modeling and screening presents a novel type of pharmacophore modeling and screening, one that depends on a reduced protein representation.

Linking Interactome to Disease

The introduction of high-throughput gene expression profiling technologies (DNA microarrays) in molecular biology and their expected applications to the clinic have allowed the design of predictive signatures linked to a particular clinical condition or patient outcome in a given clinical setting. However, it has been shown that such signatures are prone to several problems: (i) they are heavily unstable and linked to the set of patients chosen for training; (ii) data topology is problematic with regard to the data dimensionality (too many variables for too few samples); (iii) diseases such as cancer are provoked by subtle misregulations which cannot be readily detected by current analysis methods. To find a predictive signature generalizable for multiple datasets, a strategy of superimposition of a large scale of protein-protein interaction data (human interactome) was devised over several gene expression datasets (a total of 2,464 breast cancer tumors were integrated), to find discriminative regions in the interactome (subnetworks) predicting metastatic relapse in breast cancer. This method, Interactome-Transcriptome Integration (ITI), was applied to several breast cancer DNA microarray datasets and allowed the extraction of a signature constituted by 119 subnetworks. All subnetworks have been stored in a relational database and linked to Gene Ontology and NCBI EntrezGene annotation databases for analysis. Exploration of annotations has shown that this set of subnetworks reflects several biological processes linked to cancer and is a good candidate for establishing a network-based signature for prediction of metastatic relapse in breast cancer.

Addressing the Challenges of Detecting Epistasis in Genome-Wide Association Studies of Common Human Diseases Using Biological Expert Knowledge

Recent technological developments in the field of genetics have given rise to an abundance of research tools, such as genome-wide genotyping, that allow researchers to conduct genome-wide association studies (GWAS) for detecting genetic variants that confer increased or decreased susceptibility to disease. However, discovering epistatic, or gene-gene, interactions in high dimensional datasets is a problem due to the computational complexity that results from the analysis of all possible combinations of single-nucleotide polymorphisms (SNPs). A recently explored approach to this problem employs biological expert knowledge, such as pathway or protein-protein interaction information, to guide an analysis by the selection or weighting of SNPs based on this knowledge. Narrowing the evaluation to gene combinations that have been shown to interact experimentally provides a biologically concise reason why those two genes may be detected together statistically. This chapter discusses the challenges of discovering epistatic interactions in GWAS and how biological expert knowledge can be used to facilitate genome-wide genetic studies.